Beijing Chunlizhengda Medical Instruments (01858) reported a net profit attributable to shareholders of approximately RMB189 million for the first three quarters, a year-on-year decrease of 1.55%.
Chunlizhengda Medical Instruments (01858) announced its results for the first three quarters of 2026, with operating revenue of approximately RMB626 million, a year-on-year decrease of 17.14%; net profit attributable to shareholders of the listed company of approximately RMB189 million, a year-on-year decrease of 1.55%; and basic earnings per share of RMB0.49.
Beijing Chunlizhengda Medical Instruments (01858) announced its results for the first three quarters of 2026, with operating revenue of approximately RMB626 million, a year-on-year decrease of 17.14%; net profit attributable to shareholders of the listed company of approximately RMB189 million, a year-on-year decrease of 1.55%; and basic earnings per share of RMB0.49.
Related Articles
Amazon.com, Inc. (AMZN.US) Continues to Fund AI Spending: Establishes Hardware-Backed Financing Arrangement of Up to US$80 Billion, Total Spending Commitments Rise to US$883 Billion
HK Bull/Bear Outstanding Qty Ratio(43:57) | October 31
Overnight US stocks | "Black Friday" sweeps across risk assets, Nasdaq posts worst single-day performance since June; Apple Inc. (AAPL.US) market cap overtakes NVIDIA Corporation (NVDA.US) to reclaim the global top spot.
Amazon.com, Inc. (AMZN.US) Continues to Fund AI Spending: Establishes Hardware-Backed Financing Arrangement of Up to US$80 Billion, Total Spending Commitments Rise to US$883 Billion
HK Bull/Bear Outstanding Qty Ratio(43:57) | October 31
Overnight US stocks | "Black Friday" sweeps across risk assets, Nasdaq posts worst single-day performance since June; Apple Inc. (AAPL.US) market cap overtakes NVIDIA Corporation (NVDA.US) to reclaim the global top spot.
